Showing results (1871-1880 of 3,764) with videos related to

Sort By:
Pageof 377
Heart and Vessels|October 27, 2015
Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinicSatoshi Yanagisawa, Yasuya Inden, Naoki Yoshida, et al.
Heart and Vessels|November 8, 2015
Use of antiarrhythmic drugs during ablation of persistent atrial fibrillation: observations from a large single-centre cohortJakob Lüker, Arian Sultan, Susanne Sehner, et al.
Heart and Vessels|June 22, 2016
Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System®Yoshiaki Idemoto, Shin-Ichiro Miura, Kenji Norimatsu, et al.
Heart and Vessels|May 30, 2016
Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53Naoya Kataoka, Kunihiro Nishida, Koshi Kinoshita, et al.
Heart and Vessels|October 30, 2014
Changes in collagen metabolism account for ventricular functional recovery following beta-blocker therapy in patients with chronic heart failureMiho Fukui, Akiko Goda, Kazuo Komamura, et al.
Heart and Vessels|August 22, 2015
Older age is associated with greater central aortic blood pressure following the exercise stress test in subjects with similar brachial systolic blood pressureMasatake Kobayashi, Kazutaka Oshima, Yoichi Iwasaki, et al.
Heart and Vessels|August 22, 2015
Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionTsuyoshi Nozue, Masayo Yamada, Tetsuji Tsunoda, et al.
Heart and Vessels|August 16, 2015
Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillationKoji Miyamoto, Takeshi Aiba, Shoji Arihiro, et al.
Heart and Vessels|April 30, 2016
Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery diseaseTakuo Emoto, Tomoya Yamashita, Toshio Kobayashi, et al.
Heart and Vessels|April 8, 2016
Ezetimibe enhances and stabilizes anticoagulant effect of warfarinTakehiro Hashikata, Minako Yamaoka-Tojo, Ryota Kakizaki, et al.
Pageof 377